Processing your payment...
Please do not close your browser.

Human Fibrinogen Market - Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: CSL Behring, LFB, Shanghai RAAS, Boya

07 Jan, 2020 | 99 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Registering a CAGR of 14.5% over the forecast period of 2022-2027, the global human fibrinogen market is anticipated to reach the market value of US$ 1889.2 million in the year 2027 from US$ 795.8 million in the year 2020.



Human Fibrinogen Market Overview



During the projected period, the human fibrinogen concentrate market is expected to grow at a healthy rate. The rising prevalence of bleeding diseases, as well as an increase in the number of approvals for human fibrinogen concentrate, are both contributing to the market's expansion. In 2018, the United Kingdom had 11,089 persons with coagulation abnormalities, according to a survey by the United Kingdom Doctor's Hemophilia Association. In addition, LFB got regulatory approval in Europe to market the FibClot product in 2016. As a result, demand for fibrinogen concentrate is likely to increase.



Fibrinogen which is also called Factor I is a type of protein which liver releases that helps in thickening of blood. The solvent fibrinogen in blood plasma is separated in fibrins by thrombin chemical which can result in blood clump. Lower fibrinogen fixation can lead to huge blood loss and may also cause thrombosis. Thrombosis includes creation of blood clumps or clots inside the vein which blocks blood supply. Thrombosis may contain serious predicaments if blockage is found in territories which can cause stroke or heart assault. Diminished dimension of fibrinogen can result in expansive volume of blood transfusion, ceaseless liver ailment and seriously ailing health whereas lifted dimensions can result tissue harm, certain malignancies, irritation, stroke and extreme contaminations and hence the test has a wide application in determination of ailment.






Industry Updates:




  • 11 Mar 2009, CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP-

    CSL Behring has been informed by the U.S. Food and Drug Administration (FDA) that because RiaSTAP is the first FDA-approved treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, the company is entitled to seven years of orphan-drug exclusivity.

  • 15 Mar 2012, CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery-

    The purpose of this study is to demonstrate that Fibrinogen Concentrate (Human)(FCH) can reduce intraoperative bleeding and, therefore, the volume of donor blood products (e.g., fresh frozen plasma, platelets, and red blood cells) needed during complex cardiovascular surgical procedures such as aortic aneurysm surgery..



What are the major Applications, Types and Regions for Human Fibrinogen Market?



Human Fibrinogen Market is segmented based on the type, applications, companies and regions.



Market Volume (%) By Type, it is segmented into




  • Pure Human Fibrinogen

  • Fibrinogen Concentrate (Human)

  • Others



Market Volume (%) By Applications it is segmented into




  • Congenital Fibrinogen Deficiency

  • Surgical Procedures

  • Other



Human Fibrinogen Market Regional Analysis



Europe held a significant share of the global Human Fibrinogen market in 2020, followed by North America. Europe is likely to retain market share during the forecast period. High awareness about the availability of different brands of fibrinogen concentrate products and early introduction of Human Fibrinogen drive the market in the region.



All these factors greatly affect the Human Fibrinogen market growth. It further aims at providing complete overview on detailed assessment of significant features of different industries including sales value, sales volume, market revenue, and demand size, sales growth, pricing analysis and changing market growth factors in regions such as Follows,




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Human Fibrinogen Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Human Fibrinogen Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Human Fibrinogen Market report scope?



The report includes in-depth assessment of the competitive landscape, product market sizing (Value and Volume), product benchmarking, market trends, product developments, financial analysis, strategic analysis and many more to measure the impact forces and potential opportunities of the market. As well as this the report also includes a study of major developments in the market like product launches, agreements, acquisitions, collaborations, mergers and many more to comprehend the prevailing market dynamics at current and its impact in the forecast period 2012-2027.























































Report Attributes



 



Report Details



Forecast Period 2022 to 2027 CAGR (Value and Volume)



CAGR of 14.5% during the review period (2022 to 2027).



Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022)




  • Pure Human Fibrinogen

  • Fibrinogen Concentrate (Human)

  • Others



Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022)




  • Congenital Fibrinogen Deficiency

  • Surgical Procedures

  • Others



Quantitative units



Revenue in USD million/billion and CAGR from 2022 to 2027



By Companies



CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Greencross, Shanghai XinXing Medical



 



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



 



 



 



 



 



 



 



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



 



Base Year



 



 



2022



 



Historical Year



 



 



2017 to 2021



 



Forecast Year



 



 



2022 to 2027



 



Customization Available



 



 



Yes, the report can be customized as per your needs




Key Highlights from this Human Fibrinogen Report




  • A comprehensive backdrop analysis, which contains an assessment of the parent market

  • Essential changes in market dynamics.

  • Market segmentation up to the second or third level.

  • Historical, current, and projected size of the market from the standpoint of both value and volume.

  • Reporting and evaluation of recent industry developments.

  • Market shares and strategies of major players.

  • Emerging niche segments and regional markets.

  • An objective assessment of the trajectory of the market.

  • Recommendations to companies for strengthening their foothold in the market.



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.



Frequently Asked Questions



What is the study period of this market?



The Human Fibrinogen Market is studied from 2017 - 2027.



What is the growth rate of Human Fibrinogen Market?



The Human Fibrinogen Market is growing at a CAGR of 14.5% over the next 5 years.



Who are the key players in Human Fibrinogen Market?



CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Greencross, Shanghai XinXing Medical



What region does this Human Fibrinogen Market report covers?



North America (the United States, Canada, and Mexico)



Europe (Germany, France, UK, Russia, and Italy)



Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)



South America (Brazil, Argentina, Colombia, etc.)



The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)



What are the significant types of Human Fibrinogen Market?



Pure Human Fibrinogen, Fibrinogen Concentrate (Human), Others



What are the major end-use applications of Human Fibrinogen Market?



Congenital Fibrinogen Deficiency, Surgical Procedures, Others.


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL HUMAN FIBRINOGEN MARKET BY TYPES

    3. GLOBAL HUMAN FIBRINOGEN MARKET BY APPLICATION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASED DEMAND FROM APPLICATIONS

      2. INCREASING DEMAND FOR HUMAN FIBRINOGEN



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST OF RAW MATERIAL



    3. OPPORTUNITIES

      1. HUMAN FIBRINOGEN GROWTH

      2. APPLICATION OF HUMAN FIBRINOGEN



    4. IMPACT OF COVID 19



  5. GLOBAL HUMAN FIBRINOGEN MARKET, BY TYPES

    1. Introduction

    2. Pure Human Fibrinogen

    3. Fibrinogen Concentrate (Human)

    4. Others



  6. GLOBAL HUMAN FIBRINOGEN MARKET, BY APPLICATION

    1. Introduction

    2. Congenital Fibrinogen Deficiency

    3. Surgical Procedures

    4. Others



  7. GLOBAL HUMAN FIBRINOGEN MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. CSL Behring

      2. LFB

      3. Shanghai RAAS

      4. Boya

      5. Hualan Biological Engineering

      6. Harbin Pacific Biopharmaceutical

      7. Greencross

      8. Shanghai XinXing Medical

      9. Others.





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 3M
  • 3M
  • 9